Vaxart Inc (VXRT.OQ)
VXRT.OQ on NASDAQ Stock Exchange Capital Market
5.57USD
1:30am IST
5.57USD
1:30am IST
Change (% chg)
$0.20 (+3.72%)
$0.20 (+3.72%)
Prev Close
$5.37
$5.37
Open
$5.61
$5.61
Day's High
$5.65
$5.65
Day's Low
$5.40
$5.40
Volume
14,785
14,785
Avg. Vol
8,649
8,649
52-wk High
$11.88
$11.88
52-wk Low
$4.85
$4.85
About
Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include... (more)
Overall
| Beta: | 0.02 |
| Market Cap(Mil.): | $27.05 |
| Shares Outstanding(Mil.): | 38.65 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
Competitors
| Price | Chg | |
|---|---|---|
| GlaxoSmithKline plc (GSK.L) | 1,407.40 | -- |
| Gilead Sciences, Inc. (GILD.OQ) | $74.44 | -1.24 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 6,265.00 | -67.00 |
| Novavax, Inc. (NVAX.OQ) | $1.72 | -0.08 |
| Bavarian Nordic A/S (BAVA.CO) | kr.175.40 | -3.75 |
| Regeneron Pharmaceuticals Inc (REGN.OQ) | $315.83 | -5.56 |
| DAIICHI SANKYO COMPANY, LIMITED (4568.T) | ¥3,763 | +39.00 |
| CSL Limited (CSL.AX) | $159.84 | +0.04 |
| Shionogi & Co Ltd (4507.T) | ¥5,506 | -9.00 |
Estimates